Alexandria's investment-grade credit ratings, which rank in the top 10% among all publicly traded U.S.
REITs, and significant liquidity of $6.3 billion afford the company important flexibility to execute its
differentiated life science real estate platform
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.